nodes	percent_of_prediction	percent_of_DWPC	metapath
Captodiame—Promazine—ADRA1D—polycystic ovary syndrome	0.00978	0.412	CrCbGaD
Captodiame—Promazine—ADRA1B—polycystic ovary syndrome	0.00834	0.352	CrCbGaD
Captodiame—Promazine—ADRA1A—polycystic ovary syndrome	0.00562	0.237	CrCbGaD
Captodiame—DRD3—Circadian rythm related genes—NAMPT—polycystic ovary syndrome	0.00355	0.00364	CbGpPWpGaD
Captodiame—DRD3—GPCR ligand binding—ADRA1D—polycystic ovary syndrome	0.00346	0.00355	CbGpPWpGaD
Captodiame—HTR2C—GPCRs, Class A Rhodopsin-like—ADRA1A—polycystic ovary syndrome	0.00339	0.00347	CbGpPWpGaD
Captodiame—DRD3—GPCR ligand binding—ADRA1B—polycystic ovary syndrome	0.00337	0.00345	CbGpPWpGaD
Captodiame—DRD3—Class A/1 (Rhodopsin-like receptors)—ADRA1A—polycystic ovary syndrome	0.00335	0.00343	CbGpPWpGaD
Captodiame—DRD3—GPCRs, Class A Rhodopsin-like—MTNR1B—polycystic ovary syndrome	0.00333	0.00341	CbGpPWpGaD
Captodiame—HTR2C—GPCR ligand binding—PTGER3—polycystic ovary syndrome	0.00331	0.00339	CbGpPWpGaD
Captodiame—HTR2C—GPCR ligand binding—LHCGR—polycystic ovary syndrome	0.00331	0.00339	CbGpPWpGaD
Captodiame—HTR2C—GPCRs, Class A Rhodopsin-like—ADRB3—polycystic ovary syndrome	0.00326	0.00334	CbGpPWpGaD
Captodiame—DRD3—Circadian rythm related genes—TOP2A—polycystic ovary syndrome	0.00323	0.00331	CbGpPWpGaD
Captodiame—DRD3—Class A/1 (Rhodopsin-like receptors)—ADRB3—polycystic ovary syndrome	0.00323	0.0033	CbGpPWpGaD
Captodiame—DRD3—Class A/1 (Rhodopsin-like receptors)—LHB—polycystic ovary syndrome	0.00319	0.00327	CbGpPWpGaD
Captodiame—HTR2C—Class A/1 (Rhodopsin-like receptors)—FSHR—polycystic ovary syndrome	0.00318	0.00325	CbGpPWpGaD
Captodiame—DRD3—Class A/1 (Rhodopsin-like receptors)—GNRH1—polycystic ovary syndrome	0.00312	0.00319	CbGpPWpGaD
Captodiame—HTR2C—GPCR ligand binding—PTAFR—polycystic ovary syndrome	0.00309	0.00317	CbGpPWpGaD
Captodiame—HTR2C—GPCR ligand binding—ADRA1D—polycystic ovary syndrome	0.003	0.00307	CbGpPWpGaD
Captodiame—DRD3—Circadian rythm related genes—GHRL—polycystic ovary syndrome	0.003	0.00307	CbGpPWpGaD
Captodiame—HTR2C—GPCR ligand binding—ADRA1B—polycystic ovary syndrome	0.00292	0.00299	CbGpPWpGaD
Captodiame—HTR2C—Class A/1 (Rhodopsin-like receptors)—ADRA1A—polycystic ovary syndrome	0.00291	0.00298	CbGpPWpGaD
Captodiame—DRD3—Circadian rythm related genes—ADIPOQ—polycystic ovary syndrome	0.00291	0.00298	CbGpPWpGaD
Captodiame—HTR2C—GPCRs, Class A Rhodopsin-like—MTNR1B—polycystic ovary syndrome	0.00288	0.00295	CbGpPWpGaD
Captodiame—DRD3—Class A/1 (Rhodopsin-like receptors)—MTNR1B—polycystic ovary syndrome	0.00285	0.00292	CbGpPWpGaD
Captodiame—DRD3—Circadian rythm related genes—TH—polycystic ovary syndrome	0.00282	0.00289	CbGpPWpGaD
Captodiame—HTR2C—Class A/1 (Rhodopsin-like receptors)—ADRB3—polycystic ovary syndrome	0.0028	0.00287	CbGpPWpGaD
Captodiame—DRD3—GPCR ligand binding—FSHR—polycystic ovary syndrome	0.00279	0.00286	CbGpPWpGaD
Captodiame—HTR2C—Class A/1 (Rhodopsin-like receptors)—LHB—polycystic ovary syndrome	0.00276	0.00283	CbGpPWpGaD
Captodiame—HTR2C—G alpha (q) signalling events—GHRL—polycystic ovary syndrome	0.00276	0.00282	CbGpPWpGaD
Captodiame—HTR2C—Class A/1 (Rhodopsin-like receptors)—GNRH1—polycystic ovary syndrome	0.0027	0.00277	CbGpPWpGaD
Captodiame—DRD3—Circadian rythm related genes—NGFR—polycystic ovary syndrome	0.00264	0.00271	CbGpPWpGaD
Captodiame—DRD3—GPCR downstream signaling—NPB—polycystic ovary syndrome	0.00258	0.00264	CbGpPWpGaD
Captodiame—DRD3—GPCR ligand binding—ADRA1A—polycystic ovary syndrome	0.00255	0.00261	CbGpPWpGaD
Captodiame—HTR2C—Class A/1 (Rhodopsin-like receptors)—MTNR1B—polycystic ovary syndrome	0.00247	0.00253	CbGpPWpGaD
Captodiame—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—GHRL—polycystic ovary syndrome	0.00246	0.00252	CbGpPWpGaD
Captodiame—DRD3—GPCR ligand binding—ADRB3—polycystic ovary syndrome	0.00246	0.00252	CbGpPWpGaD
Captodiame—DRD3—GPCR ligand binding—LHB—polycystic ovary syndrome	0.00243	0.00249	CbGpPWpGaD
Captodiame—HTR2C—GPCR ligand binding—FSHR—polycystic ovary syndrome	0.00242	0.00248	CbGpPWpGaD
Captodiame—DRD3—GPCR ligand binding—GNRH1—polycystic ovary syndrome	0.00237	0.00243	CbGpPWpGaD
Captodiame—DRD3—Signaling by GPCR—NPB—polycystic ovary syndrome	0.00234	0.0024	CbGpPWpGaD
Captodiame—DRD3—GPCR downstream signaling—PLEKHG5—polycystic ovary syndrome	0.00233	0.00239	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—ARHGAP30—polycystic ovary syndrome	0.00229	0.00234	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—ARHGAP23—polycystic ovary syndrome	0.00229	0.00234	CbGpPWpGaD
Captodiame—DRD3—GPCR ligand binding—SCT—polycystic ovary syndrome	0.00227	0.00233	CbGpPWpGaD
Captodiame—HTR2C—GPCR downstream signaling—NPB—polycystic ovary syndrome	0.00224	0.00229	CbGpPWpGaD
Captodiame—HTR2C—GPCR ligand binding—ADRA1A—polycystic ovary syndrome	0.00221	0.00227	CbGpPWpGaD
Captodiame—DRD3—Circadian rythm related genes—NCOR1—polycystic ovary syndrome	0.00219	0.00225	CbGpPWpGaD
Captodiame—DRD3—GPCR ligand binding—MTNR1B—polycystic ovary syndrome	0.00217	0.00222	CbGpPWpGaD
Captodiame—DRD3—GPCR downstream signaling—PTGER3—polycystic ovary syndrome	0.00215	0.00221	CbGpPWpGaD
Captodiame—DRD3—GPCR downstream signaling—LHCGR—polycystic ovary syndrome	0.00215	0.00221	CbGpPWpGaD
Captodiame—HTR2C—GPCR ligand binding—ADRB3—polycystic ovary syndrome	0.00213	0.00218	CbGpPWpGaD
Captodiame—DRD3—Signaling by GPCR—PLEKHG5—polycystic ovary syndrome	0.00212	0.00217	CbGpPWpGaD
Captodiame—HTR2C—GPCR ligand binding—LHB—polycystic ovary syndrome	0.0021	0.00216	CbGpPWpGaD
Captodiame—DRD3—Class A/1 (Rhodopsin-like receptors)—GHRL—polycystic ovary syndrome	0.0021	0.00216	CbGpPWpGaD
Captodiame—HTR2C—GPCR ligand binding—GNRH1—polycystic ovary syndrome	0.00206	0.00211	CbGpPWpGaD
Captodiame—DRD3—GPCRs, Class A Rhodopsin-like—ADRB2—polycystic ovary syndrome	0.00203	0.00208	CbGpPWpGaD
Captodiame—HTR2C—Signaling by GPCR—NPB—polycystic ovary syndrome	0.00203	0.00208	CbGpPWpGaD
Captodiame—DRD3—G alpha (i) signalling events—GNAS—polycystic ovary syndrome	0.00203	0.00208	CbGpPWpGaD
Captodiame—HTR2C—GPCR downstream signaling—PLEKHG5—polycystic ovary syndrome	0.00202	0.00207	CbGpPWpGaD
Captodiame—DRD3—GPCR downstream signaling—PTAFR—polycystic ovary syndrome	0.00202	0.00206	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—ARHGAP23—polycystic ovary syndrome	0.00198	0.00203	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—ARHGAP30—polycystic ovary syndrome	0.00198	0.00203	CbGpPWpGaD
Captodiame—HTR2C—GPCR ligand binding—SCT—polycystic ovary syndrome	0.00197	0.00202	CbGpPWpGaD
Captodiame—DRD3—Signaling by GPCR—LHCGR—polycystic ovary syndrome	0.00196	0.002	CbGpPWpGaD
Captodiame—DRD3—Signaling by GPCR—PTGER3—polycystic ovary syndrome	0.00196	0.002	CbGpPWpGaD
Captodiame—DRD3—GPCR downstream signaling—ADRA1D—polycystic ovary syndrome	0.00196	0.002	CbGpPWpGaD
Captodiame—DRD3—GPCR downstream signaling—ADRA1B—polycystic ovary syndrome	0.0019	0.00195	CbGpPWpGaD
Captodiame—HTR2C—GPCR ligand binding—MTNR1B—polycystic ovary syndrome	0.00188	0.00193	CbGpPWpGaD
Captodiame—HTR2C—GPCR downstream signaling—PTGER3—polycystic ovary syndrome	0.00187	0.00191	CbGpPWpGaD
Captodiame—HTR2C—GPCR downstream signaling—LHCGR—polycystic ovary syndrome	0.00187	0.00191	CbGpPWpGaD
Captodiame—HTR2C—Signaling by GPCR—PLEKHG5—polycystic ovary syndrome	0.00184	0.00188	CbGpPWpGaD
Captodiame—DRD3—Signaling by GPCR—PTAFR—polycystic ovary syndrome	0.00183	0.00187	CbGpPWpGaD
Captodiame—HTR2C—Class A/1 (Rhodopsin-like receptors)—GHRL—polycystic ovary syndrome	0.00182	0.00187	CbGpPWpGaD
Captodiame—DRD3—Circadian rythm related genes—LEP—polycystic ovary syndrome	0.0018	0.00185	CbGpPWpGaD
Captodiame—DRD3—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	0.00178	0.00182	CbGpPWpGaD
Captodiame—HTR2C—GPCRs, Class A Rhodopsin-like—ADRB2—polycystic ovary syndrome	0.00176	0.00181	CbGpPWpGaD
Captodiame—HTR2C—GPCR downstream signaling—PTAFR—polycystic ovary syndrome	0.00175	0.00179	CbGpPWpGaD
Captodiame—DRD3—Class A/1 (Rhodopsin-like receptors)—ADRB2—polycystic ovary syndrome	0.00174	0.00178	CbGpPWpGaD
Captodiame—DRD3—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	0.00173	0.00177	CbGpPWpGaD
Captodiame—DRD3—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	0.00173	0.00177	CbGpPWpGaD
Captodiame—HTR2C—Signaling by GPCR—PTGER3—polycystic ovary syndrome	0.0017	0.00174	CbGpPWpGaD
Captodiame—HTR2C—Signaling by GPCR—LHCGR—polycystic ovary syndrome	0.0017	0.00174	CbGpPWpGaD
Captodiame—HTR2C—GPCR downstream signaling—ADRA1D—polycystic ovary syndrome	0.0017	0.00174	CbGpPWpGaD
Captodiame—HTR2C—GPCR downstream signaling—ADRA1B—polycystic ovary syndrome	0.00165	0.00169	CbGpPWpGaD
Captodiame—DRD3—GPCR ligand binding—GHRL—polycystic ovary syndrome	0.0016	0.00164	CbGpPWpGaD
Captodiame—HTR2C—Signaling by GPCR—PTAFR—polycystic ovary syndrome	0.00159	0.00163	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—FLT4—polycystic ovary syndrome	0.00158	0.00162	CbGpPWpGaD
Captodiame—DRD3—GPCR downstream signaling—FSHR—polycystic ovary syndrome	0.00158	0.00162	CbGpPWpGaD
Captodiame—DRD3—Signaling by GPCR—PDE3B—polycystic ovary syndrome	0.00157	0.00161	CbGpPWpGaD
Captodiame—DRD3—Circadian rythm related genes—PPARG—polycystic ovary syndrome	0.00157	0.00161	CbGpPWpGaD
Captodiame—HTR2C—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	0.00154	0.00158	CbGpPWpGaD
Captodiame—HTR2C—Class A/1 (Rhodopsin-like receptors)—ADRB2—polycystic ovary syndrome	0.00151	0.00155	CbGpPWpGaD
Captodiame—HTR2C—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	0.0015	0.00154	CbGpPWpGaD
Captodiame—HTR2C—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	0.0015	0.00153	CbGpPWpGaD
Captodiame—DRD3—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	0.00144	0.00148	CbGpPWpGaD
Captodiame—DRD3—Signaling by GPCR—FSHR—polycystic ovary syndrome	0.00143	0.00147	CbGpPWpGaD
Captodiame—DRD3—Circadian rythm related genes—SERPINE1—polycystic ovary syndrome	0.00142	0.00145	CbGpPWpGaD
Captodiame—HTR2C—GPCR ligand binding—GHRL—polycystic ovary syndrome	0.00139	0.00142	CbGpPWpGaD
Captodiame—DRD3—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	0.00139	0.00142	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—NPB—polycystic ovary syndrome	0.00138	0.00142	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—FLT4—polycystic ovary syndrome	0.00137	0.00141	CbGpPWpGaD
Captodiame—DRD3—GPCR downstream signaling—LHB—polycystic ovary syndrome	0.00137	0.00141	CbGpPWpGaD
Captodiame—DRD3—G alpha (i) signalling events—POMC—polycystic ovary syndrome	0.00137	0.0014	CbGpPWpGaD
Captodiame—HTR2C—GPCR downstream signaling—FSHR—polycystic ovary syndrome	0.00137	0.0014	CbGpPWpGaD
Captodiame—HTR2C—Signaling by GPCR—PDE3B—polycystic ovary syndrome	0.00136	0.0014	CbGpPWpGaD
Captodiame—DRD3—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	0.00134	0.00137	CbGpPWpGaD
Captodiame—DRD3—GPCR ligand binding—ADRB2—polycystic ovary syndrome	0.00133	0.00136	CbGpPWpGaD
Captodiame—DRD3—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	0.00131	0.00134	CbGpPWpGaD
Captodiame—DRD3—GPCR downstream signaling—SCT—polycystic ovary syndrome	0.00129	0.00132	CbGpPWpGaD
Captodiame—DRD3—Signaling by GPCR—ADRB3—polycystic ovary syndrome	0.00126	0.00129	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.00125	0.00128	CbGpPWpGaD
Captodiame—HTR2C—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	0.00125	0.00128	CbGpPWpGaD
Captodiame—DRD3—Signaling by GPCR—LHB—polycystic ovary syndrome	0.00125	0.00128	CbGpPWpGaD
Captodiame—HTR2C—Signaling by GPCR—FSHR—polycystic ovary syndrome	0.00124	0.00127	CbGpPWpGaD
Captodiame—DRD3—GPCR ligand binding—GNAS—polycystic ovary syndrome	0.00123	0.00126	CbGpPWpGaD
Captodiame—DRD3—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.00123	0.00126	CbGpPWpGaD
Captodiame—DRD3—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.00122	0.00125	CbGpPWpGaD
Captodiame—HTR2C—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	0.0012	0.00123	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—NPB—polycystic ovary syndrome	0.0012	0.00123	CbGpPWpGaD
Captodiame—HTR2C—GPCR downstream signaling—LHB—polycystic ovary syndrome	0.00119	0.00122	CbGpPWpGaD
Captodiame—DRD3—Signaling by GPCR—SCT—polycystic ovary syndrome	0.00117	0.0012	CbGpPWpGaD
Captodiame—HTR2C—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	0.00116	0.00119	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.00116	0.00118	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.00116	0.00118	CbGpPWpGaD
Captodiame—HTR2C—GPCR ligand binding—ADRB2—polycystic ovary syndrome	0.00115	0.00118	CbGpPWpGaD
Captodiame—HTR2C—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	0.00114	0.00116	CbGpPWpGaD
Captodiame—HTR2C—GPCR downstream signaling—SCT—polycystic ovary syndrome	0.00111	0.00114	CbGpPWpGaD
Captodiame—DRD3—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.00111	0.00114	CbGpPWpGaD
Captodiame—HTR2C—Signaling by GPCR—ADRB3—polycystic ovary syndrome	0.00109	0.00112	CbGpPWpGaD
Captodiame—DRD3—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.00109	0.00111	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.00109	0.00111	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.00108	0.00111	CbGpPWpGaD
Captodiame—HTR2C—Signaling by GPCR—LHB—polycystic ovary syndrome	0.00108	0.00111	CbGpPWpGaD
Captodiame—HTR2C—GPCR ligand binding—GNAS—polycystic ovary syndrome	0.00107	0.00109	CbGpPWpGaD
Captodiame—HTR2C—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.00106	0.00109	CbGpPWpGaD
Captodiame—HTR2C—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.00106	0.00108	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.00105	0.00108	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.00102	0.00105	CbGpPWpGaD
Captodiame—HTR2C—Signaling by GPCR—SCT—polycystic ovary syndrome	0.00101	0.00104	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.001	0.00103	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.001	0.00103	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000995	0.00102	CbGpPWpGaD
Captodiame—HTR2C—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.000966	0.000989	CbGpPWpGaD
Captodiame—HTR2C—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.000943	0.000966	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000937	0.00096	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000929	0.000951	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.00091	0.000932	CbGpPWpGaD
Captodiame—DRD3—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000906	0.000928	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000885	0.000907	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000863	0.000884	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000846	0.000867	CbGpPWpGaD
Captodiame—DRD3—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000828	0.000848	CbGpPWpGaD
Captodiame—DRD3—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000823	0.000843	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000805	0.000825	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000795	0.000815	CbGpPWpGaD
Captodiame—HTR2C—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000785	0.000804	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000774	0.000793	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—FST—polycystic ovary syndrome	0.000754	0.000772	CbGpPWpGaD
Captodiame—DRD3—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.00075	0.000768	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000745	0.000763	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—LHB—polycystic ovary syndrome	0.000736	0.000754	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000733	0.000751	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000719	0.000737	CbGpPWpGaD
Captodiame—HTR2C—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000718	0.000736	CbGpPWpGaD
Captodiame—HTR2C—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000713	0.00073	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000697	0.000714	CbGpPWpGaD
Captodiame—DRD3—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000695	0.000712	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—SCT—polycystic ovary syndrome	0.00069	0.000706	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.00069	0.000706	CbGpPWpGaD
Captodiame—DRD3—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000681	0.000697	CbGpPWpGaD
Captodiame—DRD3—Circadian rythm related genes—IL6—polycystic ovary syndrome	0.000674	0.00069	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000671	0.000687	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000658	0.000674	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—FST—polycystic ovary syndrome	0.000654	0.00067	CbGpPWpGaD
Captodiame—HTR2C—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.00065	0.000666	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000647	0.000662	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000646	0.000661	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000641	0.000657	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—LHB—polycystic ovary syndrome	0.000638	0.000654	CbGpPWpGaD
Captodiame—DRD3—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000631	0.000647	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000624	0.000639	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000604	0.000619	CbGpPWpGaD
Captodiame—HTR2C—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000603	0.000617	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000599	0.000613	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—SCT—polycystic ovary syndrome	0.000598	0.000612	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—GAB1—polycystic ovary syndrome	0.00059	0.000605	CbGpPWpGaD
Captodiame—HTR2C—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.00059	0.000605	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.00057	0.000584	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—INSR—polycystic ovary syndrome	0.000564	0.000578	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000561	0.000574	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000556	0.000569	CbGpPWpGaD
Captodiame—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	0.000553	0.000567	CbGpPWpGaD
Captodiame—HTR2C—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000547	0.000561	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000536	0.000549	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000528	0.000541	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—PGR—polycystic ovary syndrome	0.000523	0.000535	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000519	0.000532	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000512	0.000524	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—INSR—polycystic ovary syndrome	0.000489	0.000501	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000486	0.000498	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000486	0.000498	CbGpPWpGaD
Captodiame—DRD3—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000468	0.000479	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000465	0.000476	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000464	0.000475	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000458	0.000469	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—PGR—polycystic ovary syndrome	0.000453	0.000464	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000452	0.000463	CbGpPWpGaD
Captodiame—DRD3—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.00045	0.000461	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000428	0.000438	CbGpPWpGaD
Captodiame—DRD3—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000425	0.000435	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—PRL—polycystic ovary syndrome	0.000424	0.000434	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000421	0.000432	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000421	0.000432	CbGpPWpGaD
Captodiame—DRD3—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000409	0.000419	CbGpPWpGaD
Captodiame—HTR2C—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000406	0.000416	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000402	0.000412	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000402	0.000412	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000392	0.000401	CbGpPWpGaD
Captodiame—HTR2C—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.00039	0.0004	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000373	0.000382	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000371	0.00038	CbGpPWpGaD
Captodiame—HTR2C—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000369	0.000378	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—PRL—polycystic ovary syndrome	0.000368	0.000377	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000355	0.000364	CbGpPWpGaD
Captodiame—HTR2C—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000354	0.000363	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000349	0.000357	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000349	0.000357	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000323	0.000331	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000308	0.000316	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000302	0.00031	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000299	0.000306	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—LEP—polycystic ovary syndrome	0.000292	0.000299	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000261	0.000267	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000259	0.000265	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—LEP—polycystic ovary syndrome	0.000253	0.00026	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—POMC—polycystic ovary syndrome	0.000251	0.000257	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—INS—polycystic ovary syndrome	0.00025	0.000256	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000242	0.000247	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000241	0.000247	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000229	0.000235	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000226	0.000232	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—POMC—polycystic ovary syndrome	0.000218	0.000223	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—INS—polycystic ovary syndrome	0.000217	0.000222	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000209	0.000215	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000209	0.000214	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000199	0.000204	CbGpPWpGaD
Captodiame—DRD3—Signaling by GPCR—IL6—polycystic ovary syndrome	0.000185	0.000189	CbGpPWpGaD
Captodiame—HTR2C—Signaling by GPCR—IL6—polycystic ovary syndrome	0.00016	0.000164	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—VEGFA—polycystic ovary syndrome	0.000158	0.000162	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—VEGFA—polycystic ovary syndrome	0.000137	0.00014	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—IL6—polycystic ovary syndrome	0.000109	0.000112	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—IL6—polycystic ovary syndrome	9.46e-05	9.69e-05	CbGpPWpGaD
